Cancer therapy-related cardiovascular toxicity observed during third-generation EGFR-TKI-based treatment in EGFR-mutant NSCLC: a retrospective cohort study
Jian-Cheng Zhou, Ting Zhang, Bo-Yang Li, Jun-Jie Dong, Xiao-Jiao Cui
Springer Nature ·
2026-10-14
· DOI 10.1186/s12885-026-17095-8
The publisher did not provide an abstract — full text is available via the link below.
Jian-Cheng Zhou, Ting Zhang, Bo-Yang Li, Jun-Jie Dong, Xiao-Jiao Cui. Cancer therapy-related cardiovascular toxicity observed during third-generation EGFR-TKI-based treatment in EGFR-mutant NSCLC: a retrospective cohort study. // BMC Cancer. – 2026. – DOI: 10.1186/s12885-026-17095-8. – URL: https://doi.org/10.1186/s12885-026-17095-8
Jian-Cheng Zhou, Ting Zhang, Bo-Yang Li, Jun-Jie Dong, & Xiao-Jiao Cui (2026). Cancer therapy-related cardiovascular toxicity observed during third-generation EGFR-TKI-based treatment in EGFR-mutant NSCLC: a retrospective cohort study. BMC Cancer. https://doi.org/10.1186/s12885-026-17095-8
Jian-Cheng Zhou, et al. “Cancer therapy-related cardiovascular toxicity observed during third-generation EGFR-TKI-based treatment in EGFR-mutant NSCLC: a retrospective cohort study.” BMC Cancer, 2026. doi:10.1186/s12885-026-17095-8.
@article{Zhou2026,
title = {Cancer therapy-related cardiovascular toxicity observed during third-generation EGFR-TKI-based treatment in EGFR-mutant NSCLC: a retrospective cohort study},
author = {Zhou, Jian-Cheng and Zhang, Ting and Li, Bo-Yang and Dong, Jun-Jie and Cui, Xiao-Jiao},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-17095-8},
url = {https://doi.org/10.1186/s12885-026-17095-8}
}